Anticholinergics in the treatment of children and adults with acute asthma: A systematic review with meta-analysis

Thorax

Volumn 60, Issue 9, 2005, Pages 740-746

  Rodrigo, G J ^a,b   Castro Rodriguez, J A ^c  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b Clinica Respirar   (Uruguay)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE;

ADOLESCENT; ADULT; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; EMBASE; EMERGENCY TREATMENT; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; MEDLINE; META ANALYSIS; MULTIPLE DRUG DOSE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SPIROMETRY; SYSTEMATIC REVIEW;

EID: 24744466684     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.047803     Document Type: Review

References (47)

1. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults. A review. Chest 2004;125:1091-102.
2. National Institutes of Health. Global strategy for asthma management and prevention, NIH Publication 02-3659, 2004.
3. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: management of acute asthma. Thorax 2003;58(Suppl I):i32-50.
4. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999;107:363-70.
5. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18.
6. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews, 2000, Issue 3, CD000060.
7. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment. An evidence-based evaluation. Chest 2002;121:1977-87.
8. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
9. DerSomonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
10. Higgins JPT, Thompson SG, Deecks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
11. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
12. Beck R, Robertson C, Galdes-Sebaldt M, et al. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr 1985;107:605-68.
13. Cook JJ, Fergusson DM, Dawson KP. Ipratropium and fenoterol in the treatment of acute asthma. Pharmatherapeutica 1985;4:383-6.
14. Reisman J, Galdes-Sebaldt M, Kazim F, et al. Frequent administration of inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma children. J Allergy Clin Immunol 1988;81:16-20.
15. Watson WTA, Becker AB, Simmons FER. Comparison of ipratropium solution, fenoterol solution and their combination administered by nebulizer and face mask to children with acute asthma. J Allergy Clin Immunol 1988;82:1012-8.
16. Phanichyakam P, Kraisarin C, Sasisakulporn C. Comparison of inhaled terbutaline and inhaled terbutaline plus ipratropium bromide in acute asthmatic children. Asian Pacific J Allergy Immunol 1990;8:45-8.
17. Peterson R, Wensley D, Mitchell I, et al. Boehringer Ingelheim Trial No. 2442430, 3.1994.
18. Schuh S, Johnson DW, Callahan S, et al. Efficacy of frequent nebulized ipratropium added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 1995;126:639-45.
19. Qureshi FA, Zaritsky A, Lakkis H. Efficacy of nebulized ipratropium in severe asthmatic children. Ann Emerg Med 1997;29:205-11.
20. Calvo GM, Calvo AM, Marin HF, et al. Is it useful to add an anticholinergic treatment to beta2-adrenergic medication in acute asthma attack? J Invest Allergy Clin Immunol 1998;8:30-4.
21. Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the treatment of mild and moderate acute asthma. J Pediatr 1998;133:479-85.
22. Qureshi F, Pestian J, Davis P, et al. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339:1030-5.
23. Zorc JJ, Pusic MV, Ogborn CJ, et al. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103:748-52.
24. Benito Fernandez J, Maintegui Raso S, Sánchez Echanitz J, et al. Eficacia de la administración precoz de bromuro de ipratropio nebulizado en niños con crisis asmática. An Esp Pediatr 2000;53:217-22.
25. Sienra Monje JJL, Bermejo Guevara MA, del Rio Navarro BE, et al. Grado y duración de la broncodilatación mediante la administración de un agonista β2 solo vs un agonista β2 mas bromuro de ipratropio en niños con asma aguda. Rev Alergia México 2000;XLVII:26-9.
26. Timsit S, Sannier N, Bocquet N, et al. Apport du bromure d'ipratropium dans la prise en charge des crises d'asthme aux urgencies. Arch Pédiatr 2002;9:117-24.
27. Sharma A, Madaan A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian J Pediatr 2004;71:121-4.
28. Bryant DH. Nebulized ipratropium bromide in the treatment of acute asthma. Chest 1985;88:24-9.
29. Rebuck AS, Chapman KR, Abboud R, et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987;82:59-64.
30. Higgins RM, Stradling JR, Lane DJ. Should ipratropium be added to beta-agonists in treatment of acute severe asthma? Chest 1988;94:718-22.
31. O'Driscoll BR, Taylor RJ, Horsley MG, et al. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;i:1418-20.
32. Summers QA, Tarala RA. Nebulized ipratropium in the treatment of acute asthma. Chest 1990;97:430-4.
33. Cydulka RK, Emerman CL. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma. Ann Emerg Med 1994;23:270-4.
34. Rodrigo G, Rodrigo C. Tratamiento de la crisis asmática con altas dosis de salbutamol y bromuro de ipratropio administrados mediante inhalador de dosis medida e inhalocámara. Pac Critico 1995;8:175-84.
35. Karpel JP, Schacter EN, Fanta Ch, et al. A comparison of ipratropium and albuterol vs. albuterol alone for the treatment of acute asthma. Chest 1996;110:611-6.
36. FitzGerald JM, Grunfeld A, Pare PD, et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs. nebulized adrenergic bronchodilator alone in acute asthma. Chest 1997;111:311-5.
37. Garret JE, Town GI, Rodwell P, et al. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. J Allergy Clin Immunol 1997;100:165-70.
38. Lin RY, Pesola GR, Bakalchuk L, et al. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med 1998;31:208-13.
39. Kamei T, Fujita J, Okada H, et al. Comparison between fenoterol and fenoterol plus oxytropium bromide delivered by metered-dose inhaler with inspirease to relief acute asthma attack. J Asthma 1999;36:67-75.
40. Weber EJ, Levitt A, Covington JK, et al. E. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. Chest 1999;115:937-44.
41. Nakano Y, Enomoto N, Kawamoto A, et al. Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma. J Allergy Clin Immunol 2000;106:472-8.
42. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000;161:1862-8.
43. Aggarwal P, Singh O, Wali JP, et al. Efficacy of nebulised ipratropium in acute bronchial asthma. J Indian Acad Clin Med 2002;3:353-9.
44. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma. An evidence-based evaluation. Chest 1999;116:285-95.
45. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews, 2001, Issue 1, CD002178.
46. Santanello NC, Zhang J, Seidenberg B, et al. What are minimal important changes for asthma measures in clinical trial? Eur Respir J 1999;14:23-7.
47. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999;354:1896-900.